tiprankstipranks
Advertisement
Advertisement

KYTX Stock Latest News

Kyverna Therapeutics files $300M mixed securities shelf
The FlyKyverna Therapeutics files $300M mixed securities shelf
13d ago
KYTX
Kyverna Therapeutics reports Q4 EPS (80c), consensus (86c)
PremiumThe Fly
Kyverna Therapeutics reports Q4 EPS (80c), consensus (86c)
13d ago
KYTX
Kyverna Therapeutics Strengthens Board With New Director Appointments
PremiumCompany Announcements
Kyverna Therapeutics Strengthens Board With New Director Appointments
1M ago
8K
KYTX
Kyverna Therapeutics appoints Sravan Emany, Andrew Miller to board
PremiumThe Fly
Kyverna Therapeutics appoints Sravan Emany, Andrew Miller to board
1M ago
BEAM
KYTX
Kyverna Therapeutics Appoints New CTO to Drive CAR-T Manufacturing
PremiumCompany Announcements
Kyverna Therapeutics Appoints New CTO to Drive CAR-T Manufacturing
2M ago
8K
KYTX
Kyverna Therapeutics appoints Pujols as Chief Technology Officer
PremiumThe FlyKyverna Therapeutics appoints Pujols as Chief Technology Officer
2M ago
KYTX
Kyverna Therapeutics: Strong Early Autoimmune CAR-T Data, Accelerated SPS Timeline, and Solid Cash Runway Support Buy Rating
Premium
Ratings
Kyverna Therapeutics: Strong Early Autoimmune CAR-T Data, Accelerated SPS Timeline, and Solid Cash Runway Support Buy Rating
3M ago
KYTX
Kyverna Therapeutics Names Christi Shaw Executive Board Chair
Premium
Company Announcements
Kyverna Therapeutics Names Christi Shaw Executive Board Chair
3M ago
8K
KYTX
Kyverna Therapeutics provides corporate update, priorities for 2026
PremiumThe Fly
Kyverna Therapeutics provides corporate update, priorities for 2026
3M ago
KYTX
Kyverna Therapeutics Announces $100 Million Public Offering
PremiumCompany Announcements
Kyverna Therapeutics Announces $100 Million Public Offering
4M ago
8K
KYTX
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
PremiumThe Fly
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
4M ago
PG
ABM
Kyverna prices 13.3M shares at $7.50 in underwritten public offering
PremiumThe Fly
Kyverna prices 13.3M shares at $7.50 in underwritten public offering
4M ago
KYTX
Kyverna Therapeutics price target raised to $33 from $31 at Wells Fargo
PremiumThe FlyKyverna Therapeutics price target raised to $33 from $31 at Wells Fargo
4M ago
KYTX
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
4M ago
IMNM
KYTX
Closing Bell Movers: Ford nudges higher raised outlook, EV charge
Premium
The Fly
Closing Bell Movers: Ford nudges higher raised outlook, EV charge
4M ago
F
F
Kyverna Therapeutics offers to sell $100M in common stock
PremiumThe Fly
Kyverna Therapeutics offers to sell $100M in common stock
4M ago
KYTX
Kyverna Therapeutics’ Promising KYSA-8 Study and Strategic Plans Bolster Buy Rating
PremiumRatings
Kyverna Therapeutics’ Promising KYSA-8 Study and Strategic Plans Bolster Buy Rating
4M ago
KYTX
Leerink raises Kyverna price target, says KYSA-8 study results transformative
PremiumThe Fly
Leerink raises Kyverna price target, says KYSA-8 study results transformative
4M ago
KYTX
Kyverna Therapeutics price target raised to $33 from $25 at Morgan Stanley
PremiumThe Fly
Kyverna Therapeutics price target raised to $33 from $25 at Morgan Stanley
4M ago
KYTX
Kyverna Therapeutics: Promising Outlook with Breakthrough CAR-T Therapy in Autoimmune Diseases
PremiumRatingsKyverna Therapeutics: Promising Outlook with Breakthrough CAR-T Therapy in Autoimmune Diseases
4M ago
KYTX
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
Premium
The Fly
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
4M ago
KO
COR
Kyverna Therapeutics Inc trading resumes
Premium
The Fly
Kyverna Therapeutics Inc trading resumes
4M ago
KYTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >